PhRMA highlights potential savings of outcomes-based contracts
PhRMA found that in the past two years, patients with HIV, high cholesterol and diabetes whose health plans implemented value-based contracts for their medications had 28% lower out-of-pocket costs, on average, than patients in other plans.